Significant variability in symptoms and disease burden exists among myasthenia gravis patients across MGFA classes, challenging the use of MGFA classification for individual prognosis. Many patients ...
“However, it is not completely understood how specific variant classes modify clinical features across different methods of ascertainment — how sample cohorts are selected and studied — and primary ...
A phase II trial to evaluate the safety and efficacy of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, as a monotherapy in patients with advanced NSCLC. This is an ASCO Meeting Abstract from ...
Like angioedema in general, hereditary angioedema (HAE) is characterized by subcutaneous or submucosal edema that is nonpruritic — ie, does not itch — and nonpitting — ie, does not leave an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results